Protecting babies from RSV during pregnancy and after birth
Treatments studied
Part of Infections, Women’s health & pregnancy clinical trials.
This study tests two approved ways to prevent RSV, a common virus that can make babies very sick. Pregnant women may get a vaccine, and/or their babies may get an antibody shot after birth. The study compares these options to see which works best.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and between 24 and 36 weeks along.
- You are willing to receive a vaccine during pregnancy if assigned to that group.
- You are willing for your baby to receive an antibody shot after birth if assigned to that group.
- You are expecting only one baby (not twins or more).
- You have not already received an RSV prevention product during this pregnancy.
- You are able to fill out a health questionnaire online in a language it's available in.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests giving a medicine called nirsevimab to newborns and a possible vaccine to pregnant mothers to prevent RSV, a serious lung infection in babies. It checks if combining both is safe and works better than nirsevimab alone.
This study tests a vaccine (called RSVpreF) for pregnant people living with HIV. The vaccine is meant to boost your own immunity so you can pass protection to your baby against RSV, a common and sometimes dangerous respiratory infection.
This study uses smartphone technology to help new parents get RSV protection for their babies. RSV is a common virus that can cause serious breathing problems in infants, and this trial tests whether AI-assisted reminders can improve prevention rates.
This study tests an approved RSV vaccine given to pregnant women. The goal is to see if it safely protects their babies from severe RSV lung infections during the first months of life.
This study looks at how well the RSV vaccine given to pregnant women (called ABRYSVO) protects babies from getting RSV after birth. It uses national health data from Scotland to track health outcomes.
This study tests an RSV antibody shot that helps protect babies from severe RSV. It aims to see how well this preventive shot works in Aboriginal and Torres Strait Islander infants when given around 6-9 months of age.
Hear when a new RSV Immunization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.